Quantedge Capital Pte LTD Alkermes Plc. Transaction History

Quantedge Capital Pte LTD

  • $328 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$22.0 - $31.87 $1.8 Million - $2.61 Million
-81,900 Reduced 62.85%
48,400 $1.08 Million
Q2 2022

Aug 12, 2022
BUY
$26.4 - $30.54 $3.44 Million - $3.98 Million
130,300 New
130,300 $3.88 Million
Q1 2022

May 13, 2022
SELL
$23.07 - $27.99 $613,662 - $744,534
-26,600 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$21.47 - $32.08 $571,102 - $853,328
26,600 New
26,600 $619,000

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Quantedge Capital Pte LTD Portfolio

Follow Quantedge Capital Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quantedge Capital Pte LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email